Department of Hearing and Speech Sciences, Vanderbilt University Medical Center, 1215 21st Avenue South, 9302 MCE South Tower, Nashville, TN 37232, USA.
Department of Hearing and Speech Sciences, Vanderbilt University Medical Center, 1215 21st Avenue South, 9302 MCE South Tower, Nashville, TN 37232, USA.
Otolaryngol Clin North Am. 2021 Dec;54(6):1181-1191. doi: 10.1016/j.otc.2021.08.002.
In 2020, the lower age limit for pediatric cochlear implant candidacy was lowered from 12 to 9 months of age. However, audiometric-based criteria for pediatric cochlear implant candidacy have remained unchanged for more than 20 years, requiring bilateral profound sensorineural hearing loss for children less than 2 years and bilateral severe-to-profound sensorineural hearing loss for children 2 years and older. Despite the static audiometric criteria, there is an increasing literature base demonstrating significant benefits for pediatric cochlear implant recipients who exceed current Food and Drug Administration-labeled indications for cochlear implantation.
2020 年,儿科人工耳蜗植入候选者的年龄下限从 12 个月降低至 9 个月。然而,基于听力测试的儿科人工耳蜗植入候选者标准 20 多年来一直没有改变,要求 2 岁以下儿童双侧极重度感音神经性听力损失,2 岁及以上儿童双侧重度至极重度感音神经性听力损失。尽管听力测试标准保持不变,但越来越多的文献表明,对于超出当前食品和药物管理局规定的人工耳蜗植入适应证的儿科人工耳蜗植入受者,存在显著获益。